학술논문
Long-term follow up of the combination of ofatumumab, high-dose methylprednisolone, and lenalidomide for untreated chronic lymphocytic leukemia with biomarker analysis
Document Type
Article
Author
Source
In: Clinical Lymphoma, Myeloma and Leukemia . (Clinical Lymphoma, Myeloma and Leukemia, June 2024, 24(6):382-391.e2)
Subject
Language
English
ISSN
21522669
21522650
21522650